Hemostemix
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Hemostemix generated cash of -$1,419,761, which is more than the previous year. Cash used in financing activities reached the amount of $1,439,431 last year. Net change in cash is therefore $19,670.
Cash Flow
| 2014 | -3.13M | -33.20K | 6.12M |
|---|---|---|---|
| 2015 | -3.54M | -23.29K | 769.51K |
| 2016 | -2.69M | -1.53K | 2.22M |
| 2017 | -3.21M | -1.25M | 7.13M |
| 2018 | -2.68M | 0 | 201.64K |
| 2019 | -3.40M | -6.13K | 1.96M |
| 2020 | -5.97M | 0 | 6.20M |
| 2021 | -3.47M | 171.11K | 3.26M |
| 2022 | -6.10M | 0 | 6.01M |
| 2023 | -1.41M | 0 | 1.43M |
HEM.V Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 135.74K | 219.44K | 257.95K | 24.06K | 1.47M | 3.95M | 34.83K | 506.58K | 3.30M | 351.19K |
Operating activities | ||||||||||
Net income | -2.50M | -5.23M | -6.28M | -7.76M | -4.86M | -6.18M | -3.45M | -3.78M | -3.98M | -4.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 223 | 495 | 1.10K | 2.44K | 1.68K | 0 | -745.61K | 38.55K | 36.87K | 31.81K |
Stock-based compensation expense | 149.89K | 178.68K | 361.6K | 2.32M | 333.25K | 0 | 454.26K | 0 | 0 | 490.78K |
| Deferred income tax benefit | 149.89K | 178.68K | 361.6K | 2.32M | 333.25K | 0 | 454.26K | 0 | 0 | 490.78K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 113.87K | 203.76K | 1.72M | -1.98M | 115.45K | 0 | 70.90K | 0 | 231.35K | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 709.66K | -395.46K | 0 | 0 | 0 |
Cash generated by operating activities | -1.41M | -6.10M | -3.47M | -5.97M | -3.40M | -2.68M | -3.21M | -2.69M | -3.54M | -3.13M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | -1.25M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 4 | 0 | 0 | 0 | -6.13K | 0 | 0 | -1.53K | -23.29K | -33.20K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 171.11K | 0 | -6.13K | 0 | -1.25M | -1.53K | -23.29K | -33.20K |
Financing activities | ||||||||||
Common Stock Issued | 1.50M | 3.45M | 839.92K | 8.76M | 0 | 0 | 5.86M | 0 | 647.87K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 2.75M | -175K | -3.91M | 1.96M | 0 | 1.25M | 0 | 0 | 0 |
Cash used in financing activities | 1.43M | 6.01M | 3.26M | 6.20M | 1.96M | 201.64K | 7.13M | 2.22M | 769.51K | 6.12M |
Net Change In Cash | 19.67K | -83.69K | -38.50K | 233.88K | -1.44M | -2.48M | 3.92M | -471.74K | -2.79M | 2.95M |
Cash at end of period | 155.41K | 135.74K | 219.44K | 257.95K | 24.06K | 1.47M | 3.95M | 34.83K | 506.58K | 3.30M |